ARCHIVES

PET Tracer Drug Approved, Developed At Weill Cornell

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

January 31, 1986

In Brief: NCAB Will Consider Holding “Circuit Rider” Meetings; Kaplan Asked to Speak On Hybridomas

May 1, 1981

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

Organ Systems Working Group Chairs Ask for Set-Aside Funds

December 6, 1985

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010